Skip To Main Content
Jonathan Spicer on Muck Rack

Jonathan Spicer

Verified
Istanbul
As seen in: Reuters, MSN, MSN Australia, MSN Canada, MSN Ireland, MSN Money Canada, MSN Philippines, MSN Singapore, MSN UK, Arthritis & Rheumatology, Business Insider and
Reuters bureau chief in Turkey. Previously covered U.S. economy. Native of Canada. Views my own; re-tweets my curiosities.

Get in touch with Jonathan

Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Stepping off the Stage and into Biology: Reimagining the Framework for Resectable Disease in Thoracic Oncology

|
By Jonathan Spicer Verified, Heidi Paine
| jtcvs.org
Affiliations & Notes 1Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, Canada 2Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, Canada Article Info Publication History: Received July 20, 2026; Revised August 14, 2026; Accepted August 23, 2026; Published online August 28, 2026 DOI: 10.1016/j.jtcvs.2026.08.020 External LinkAlso available on ScienceDirect External Link Linked Articles
Open in Who Shared Issue with article?

Biomarkers of nivolumab benefit in resectable non-small cell lung cancer

|
By Tina Cascone, Mark Awad, Jonathan Spicer Verified, Jie He, Shun Lu, Fumihiro Tanaka, Robin Cornelissen, Lubos Petruzelka, Yang Gao Verified, Jean-Louis Pujol, Hiroyuki Ito, Tudor-Eliade Ciuleanu, Lin Wu, Sabine Bohnet, Yasutaka Watanabe, Janis Taube, Julie Stein Deutsch, Yu-Han Hung, Padma Sathyanarayana, Sumeena Bhatia, Katherine Chu, Steven Blum Verified, Stefano Lucherini, Akshay Yadav, Mariano Provencio, Cinthya Coronado Erdmann, Stephanie Meadows-Shropshire, Jaclyn Neely, Virginia Ip, Nathanial Eddy
| Nature Verified
Abstract Perioperative nivolumab significantly improved event-free survival (EFS) compared with placebo in patients with resectable non-small cell lung cancer (NSCLC) in the CheckMate 77T study (ClinicalTrials.gov NCT04025879)1. Here, after randomization, 98 out of 229 patients who received nivolumab and 92 out of 232 patients who received placebo had evaluable biomarkers (41% of randomized patients).
Open in Who Shared Issue with article?

Trump's visit a win for Turkey's Erdogan, NATO tensions aside

|
By Tuvan Gumrukcu Verified, Huseyin Hayatsever Verified, Jonathan Spicer Verified
| MSN UK Verified
By Tuvan Gumrukcu, Huseyin Hayatsever and Jonathan Spicer ANKARA, July 8 (Reuters) - Turkey put on a red-white-and-blue air show and named a new airport building after President Donald Trump, seeking to take its relationship with the U.S. to new heights at a NATO summit in Ankara, even as the U.S. leader lashed out at others in the defence alliance.
Open in Who Shared View Duplicates (129) Issue with article?
See all 8,129 licensed articles (8,602 Total)